INVESTMENT AGREEMENT dated as of December 9, 2010 between MOLECULAR INSIGHT PHARMACEUTICALS, INC. and SAVITR CAPITAL LLCInvestment Agreement • February 24th, 2011 • Savitr Capital, LLC • Pharmaceutical preparations • New York
THIS INVESTMENT AGREEMENT (together with all exhibits and schedules hereto and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms hereof, the “Agreement”), dated as of December 9, 2010, by and among Savitr Capital LLC, a Delaware limited liability company (the “Investor”) and Molecular Insight Pharmaceuticals, a Massachusetts corporation (the “Company”) and its successors, including, as the context may require, on or after the Effective Date, as reorganized pursuant to the Bankruptcy Code.
SECOND AMENDMENT TO THE INVESTMENT AGREEMENTInvestment Agreement • February 24th, 2011 • Savitr Capital, LLC • Pharmaceutical preparations • New York
This Second Amendment (the “Amendment”) to the Investment Agreement, dated as of December 9, 2010 (as amended, the “Investment Agreement”), by and between Savitr Capital LLC, a Delaware limited liability company (the “Investor”) and Molecular Insight Pharmaceuticals, Inc. a Massachusetts corporation (the “Company”), is made and entered into as of January 31, 2011, by and between the Company and the Investor. All capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the Investment Agreement.
